N-甲基庚酰胺 | 3400-24-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: N-甲基庚酰胺
• 英文名称: N-methylheptanamide
• 英文别名: N-Methyl-oenanthsaeure-amid；Heptanamide, N-methyl-
• CAS: 3400-24-6
• 化学式: C₈H₁₇NO
• 分子量: 143.229
• InChiKey: PRCOHDSOXCGBAX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2924199090

反应信息

• 作为反应物：
  描述：

  N-甲基庚酰胺 在 p-nitrated calixarene 作用下， 以 乙腈 为溶剂， 生成 N-methyl-N-nitrosoheptanamide
  参考文献：
  名称：

  Supramolecular fixation of NO2 with calix[4]arenes

  摘要：

  在路易斯酸存在下，氮氧化物与简单冠醚[4]芳烃在氯仿中的反应迅速导致强烈的颜色变化，这是由于亚硝镎离子的包合作用所致。

  DOI：

  10.1039/b207901a
• 作为产物：
  描述：

  N-甲氧基-N-甲基庚酰胺 在 N,N,N',N'-tetramethyl-7,8-dihydro-6H-dipyrido[1,2-a;2',1'-c][1,4]diazepine-2,12-diamine 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以43%的产率得到N-甲基庚酰胺
  参考文献：
  名称：

  Metal-Free Reductive Cleavage of N-O Bonds in Weinreb Amides by an Organic Neutral Super-Electron Donor

  摘要：

  作为还原剂的中性有机超电子供体的范围已经扩大到包括还原性裂解 Weinreb 酰胺中的 N-O 键。事实证明，这种方法适用于大量底物，能以良好到极佳的产率得到还原的对应物。在一组测试的酰胺中，反应性的变化是合理的。

  DOI：

  10.1055/s-2008-1078240

文献信息

• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 POLYPEPTIDES
  申请人：Arvinas, Inc.

  公开号：US20190151295A1

  公开（公告）日：2019-05-23

  The present disclosure relates to bifunctional compounds, which find utility as modulators of Interleukin-1 Receptor-Associated Kinase 4 (IRAK-4); the target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hppel-Lindau, cereblon, ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为白细胞介素-1受体相关激酶4（IRAK-4；目标蛋白）的调节剂具有实用性。具体而言，本公开涉及包含一端结合E3泛素连接酶的Von Hppel-Lindau、cereblon配体的双功能化合物，另一端结合目标蛋白的部分，使得目标蛋白靠近泛素连接酶以实现目标蛋白的降解（和抑制）。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。
• [EN] RAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] AGENTS DE DÉGRADATION DE LA PROTÉINE RAS, COMPOSITIONS PHARMACEUTIQUES DE CEUX-CI ET LEURS APPLICATIONS THÉRAPEUTIQUES
  申请人：BIOTHERYX INC

  公开号：WO2021051034A1

  公开（公告）日：2021-03-18

  Provided herein are RAS protein degraders, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RAS-mediated disorder, disease, or condition.

  本文提供了RAS蛋白降解剂，例如化合物式（I）的化合物，以及其药物组合物。本文还提供了它们用于治疗、预防或改善RAS介导的疾病、疾病或症状的方法。
• Tandem Transformation of Aldoximes to N‐Methylated Amides Using Methanol
  作者：Bhaskar Paul、Milan Maji、Dibyajyoti Panja、Sabuj Kundu

  DOI：10.1002/adsc.201900962

  日期：2019.12.3

  Tandem conversion of aldoximes to N‐methylated amides with methanol in presence of a single Ru(II) catalyst is accomplished through the Ru(II)‐mediated rearrangement followed by the reductive N‐methylation. Employing this protocol, several aldoximes were directly transformed to the N‐methylated amides using methanol. Kinetic experiments with H218O advocated that the aldoxime is acted as the nucleophile

  在单一Ru（II）催化剂存在下，用甲醇将醛肟肟串联转化为N-甲基化酰胺是通过Ru（II）介导的重排，然后进行还原性N-甲基化来实现的。采用该方案，使用甲醇将几种醛肟直接转化为N-甲基化酰胺。用H 2 18 O进行的动力学实验表明，在醛肟到酰胺的重排过程中，醛肟是亲核试剂。通过动力学研究实现了腈中间体在该转化过程中的参与。
• [EN] MODULATORS OF ESTROGEN RECEPTOR PROTEOLYSIS AND ASSOCIATED METHODS OF USE<br/>[FR] MODULATEURS DU RÉCEPTEUR DES ŒSTROGÈNES DE PROTÉOLYSE ET PROCÉDÉS D'UTILISATION ASSOCIÉS
  申请人：ARVINAS INC

  公开号：WO2018140809A1

  公开（公告）日：2018-08-02

  The present disclosure relates to bifunctional compounds, which find utility as modulators of estrogen receptor (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a cereblon, Von Hippel-Lindau ligase-binding moiety, Inhibitors of Apotosis Proteins, or mouse double-minute homolog 2 ligand, which binds to the respective E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为雌激素受体（靶蛋白）的调节剂具有实用性。具体而言，本公开涉及包含一端为 cereblon、Von Hippel-Lindau 配体结合基团、凋亡抑制蛋白或鼠双分子同源物 2 配体的双功能化合物，该化合物与相应的 E3 泛素连接酶结合，并且另一端含有结合靶蛋白的基团，使得靶蛋白与泛素连接酶靠近，以实现对靶蛋白的降解（和抑制）。本公开展示了与靶蛋白的降解/抑制相关的广泛药理活性范围。本公开的化合物和组合物用于治疗或预防由靶蛋白聚集或积累导致的疾病或紊乱。
• CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
  申请人：Arvinas, Inc.

  公开号：US20180215731A1

  公开（公告）日：2018-08-02

  The description relates to cereblon E3 ligase binding compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present disclosure. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.

  该描述涉及cereblon E3连接酶结合化合物，包括包含相同成分的双功能化合物，这些化合物作为靶向泛素化的调节剂具有实用价值，尤其是抑制剂，可降解和/或以其他方式抑制根据本公开的双功能化合物。特别是，该描述提供了化合物，其一端含有与cereblon E3泛素连接酶结合的配体，另一端含有与目标蛋白结合的部分，使目标蛋白位于泛素连接酶附近以降解（和抑制）该蛋白。可以合成表现出广泛药理活性的化合物，与几乎所有类型的靶向多肽的降解/抑制一致。